In the study, it was shown that oral administration of e-As4S4 significantly increased arsenic accumulation and eliminated ROS from tumor tissues and reduced angiogenesis, inflammasome in the tumor microenvironment by inhibiting the expression of inducible factor-1α (HIF-1α), thereby inhibiting NLRP3 expression. The gene discussed is HIF1A; the disease is neoplasm.